Loading viewer...
earnings_deck
Format: PDF earnings_deck
This document presents Azenta Life Sciences' financial results for Q1 FY 2023, highlighting revenue growth, EPS, and strategic initiatives.
Appendix 4D and FY2026 Half Year Financial Report
earnings_deck
Noxopharm
earnings_deck
R1 RCM
earnings_deck
Linde
earnings_deck
KKR & Co